https://ipharmag.com/article/supercharged-natural-killer-cells-cancer-stanford iPharmag en 2026-08-26T04:44:12+00:00 Scientists ‘Supercharge’ Natural Killer Cells to Break Into Solid Tumors https://ipharmag.com/article/shingles-vaccine-shingrix-lower-dementia-risk iPharmag en 2026-08-26T04:44:12+00:00 Shingles Vaccine Tied to 24% Lower Dementia Risk in Large Study — but Cause Isn’t Proven https://ipharmag.com/article/massachusetts-biopharma-2026-tale-two-massbio iPharmag en 2026-08-26T04:44:12+00:00 Massachusetts Biopharma in 2026: Record Funding, Shrinking Payrolls https://ipharmag.com/article/gsk-hibsago-bepirovirsen-hepatitis-b-functional-cure-japan iPharmag en 2026-08-26T04:44:12+00:00 GSK Wins First-Ever Approval for a Hepatitis B ‘Functional Cure’ in Japan https://ipharmag.com/article/abbott-libre-duo-glucose-ketone-wearable-fda iPharmag en 2026-08-26T04:44:12+00:00 FDA Clears the First Wearable That Tracks Both Blood Sugar and Ketones at Once https://ipharmag.com/article/her3-dxd-olaparib-parp-combination-nsclc iPharmag en 2026-08-25T03:34:54+00:00 Pairing a ‘Smart Bomb’ Drug With a PARP Blocker Hit Lung Cancer Harder in Lab Tests https://ipharmag.com/article/gossamer-bio-250m-funding-seralutinib-pah iPharmag en 2026-08-25T03:34:54+00:00 Gossamer Bio Lines Up Up to $250M Tied to Its Lung-Disease Drug’s FDA Filing https://ipharmag.com/article/fda-generative-ai-medical-device-regulation-plans iPharmag en 2026-08-25T03:34:54+00:00 FDA Signals New Rules Are Coming for Generative AI in Medical Devices https://ipharmag.com/article/androgens-sympathetic-neurons-lung-allergy-asthma iPharmag en 2026-08-25T03:34:54+00:00 Why Asthma Flips Between the Sexes at Puberty: Hormones Acting on Nerves, Mouse Study Suggests https://ipharmag.com/article/amazon-expressable-speech-therapy-benefits-connector iPharmag en 2026-08-25T03:34:54+00:00 Amazon Adds Virtual Speech Therapy to Its Health Benefits Marketplace https://ipharmag.com/article/rznomics-lilly-gateway-labs-rna-therapeutics iPharmag en 2026-08-24T16:42:03+00:00 RNA-Therapeutics Firm Rznomics Joins Lilly’s San Diego Incubator https://ipharmag.com/article/roche-hanmi-hm17321-obesity-lean-mass-deal iPharmag en 2026-08-24T16:42:03+00:00 Roche Bets $2.5B on an Obesity Drug That Aims to Spare Muscle https://ipharmag.com/article/regenxbio-rgx121-fda-clinical-hold-hunter-syndrome iPharmag en 2026-08-24T16:42:03+00:00 FDA Halts Regenxbio’s Hunter Syndrome Gene Therapy Again Over Spine Scan Findings https://ipharmag.com/article/jnj-tecvayli-teclistamab-daratumumab-ec-approval-myeloma iPharmag en 2026-08-24T16:42:03+00:00 J&J’s Tecvayli Wins EU Nod in a Combination That Slashed Myeloma Progression Risk https://ipharmag.com/article/common-medications-alter-gut-microbiome-years iPharmag en 2026-08-24T16:42:03+00:00 Common Medications May Reshape Your Gut Microbiome for Years, Study Finds